iSAM Funds UK Ltd Acquires New Stake in Marsh & McLennan Companies, Inc. $MRSH

iSAM Funds UK Ltd bought a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 8,800 shares of the financial services provider’s stock, valued at approximately $1,467,000. Marsh & McLennan Companies makes up approximately 1.0% of iSAM Funds UK Ltd’s investment portfolio, making the stock its 18th largest holding.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MRSH. Brighton Jones LLC raised its stake in shares of Marsh & McLennan Companies by 51.2% in the 4th quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock worth $1,856,000 after buying an additional 2,960 shares in the last quarter. Bison Wealth LLC grew its holdings in Marsh & McLennan Companies by 39.6% during the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock worth $651,000 after acquiring an additional 869 shares during the period. Glenview Trust co grew its holdings in Marsh & McLennan Companies by 10.8% during the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock worth $852,000 after acquiring an additional 379 shares during the period. Osterweis Capital Management Inc. raised its position in Marsh & McLennan Companies by 18,440.0% in the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock worth $203,000 after acquiring an additional 922 shares in the last quarter. Finally, Diversify Advisory Services LLC acquired a new stake in Marsh & McLennan Companies in the 2nd quarter valued at about $1,307,000. 87.99% of the stock is owned by institutional investors.

Marsh & McLennan Companies Trading Up 0.1%

MRSH stock opened at $187.79 on Thursday. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $207.82. The firm’s 50-day moving average price is $184.24. The stock has a market capitalization of $89.62 billion, a price-to-earnings ratio of 22.96, a PEG ratio of 2.60 and a beta of 0.58. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22.

Marsh & McLennan Companies (NYSE:MRSH) last released its earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.89 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The business had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies’s quarterly revenue was up 6.2% compared to the same quarter last year. On average, equities research analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.44 earnings per share for the current year.

Marsh & McLennan Companies Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Thursday, July 23rd were given a dividend of $0.99 per share. This represents a $3.96 annualized dividend and a yield of 2.1%. The ex-dividend date was Thursday, July 23rd. This is a positive change from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. Marsh & McLennan Companies’s dividend payout ratio is presently 48.41%.

Analysts Set New Price Targets

MRSH has been the topic of several recent research reports. Mizuho lifted their price objective on shares of Marsh & McLennan Companies from $197.00 to $201.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 22nd. Wells Fargo & Company raised their target price on shares of Marsh & McLennan Companies from $186.00 to $188.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 22nd. Weiss Ratings upgraded shares of Marsh & McLennan Companies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 7th. JPMorgan Chase & Co. increased their price objective on Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Finally, Cantor Fitzgerald raised their price objective on Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $203.50.

Insider Buying and Selling at Marsh & McLennan Companies

In related news, insider Martin South sold 7,100 shares of the company’s stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the transaction, the insider directly owned 16,632 shares of the company’s stock, valued at approximately $3,159,913.68. The trade was a 29.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Lloyd M. Yates sold 12,000 shares of the stock in a transaction dated Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total value of $2,107,800.00. Following the completion of the sale, the director directly owned 12,001 shares of the company’s stock, valued at approximately $2,107,975.65. This represents a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 19,813 shares of company stock valued at $3,597,903 in the last three months. 0.38% of the stock is currently owned by company insiders.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.